• Je něco špatně v tomto záznamu ?

Fluorescence optical imaging in anticancer drug delivery

T. Etrych, H. Lucas, O. Janoušková, P. Chytil, T. Mueller, K. Mäder,

. 2016 ; 226 (-) : 168-81. [pub] 20160216

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000439

In the past several decades, nanosized drug delivery systems with various targeting functions and controlled drug release capabilities inside targeted tissues or cells have been intensively studied. Understanding their pharmacokinetic properties is crucial for the successful transition of this research into clinical practice. Among others, fluorescence imaging has become one of the most commonly used imaging tools in pre-clinical research. The development of increasing numbers of suitable fluorescent dyes excitable in the visible to near-infrared wavelengths of the spectrum has significantly expanded the applicability of fluorescence imaging. This paper focuses on the potential applications and limitations of non-invasive imaging techniques in the field of drug delivery, especially in anticancer therapy. Fluorescent imaging at both the cellular and systemic levels is discussed in detail. Additionally, we explore the possibility for simultaneous treatment and imaging using theranostics and combinations of different imaging techniques, e.g., fluorescence imaging with computed tomography.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000439
003      
CZ-PrNML
005      
20170118113946.0
007      
ta
008      
170103s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jconrel.2016.02.022 $2 doi
024    7_
$a 10.1016/j.jconrel.2016.02.022 $2 doi
035    __
$a (PubMed)26892751
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Etrych, Tomáš $u Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. Electronic address: etrych@imc.cas.cz.
245    10
$a Fluorescence optical imaging in anticancer drug delivery / $c T. Etrych, H. Lucas, O. Janoušková, P. Chytil, T. Mueller, K. Mäder,
520    9_
$a In the past several decades, nanosized drug delivery systems with various targeting functions and controlled drug release capabilities inside targeted tissues or cells have been intensively studied. Understanding their pharmacokinetic properties is crucial for the successful transition of this research into clinical practice. Among others, fluorescence imaging has become one of the most commonly used imaging tools in pre-clinical research. The development of increasing numbers of suitable fluorescent dyes excitable in the visible to near-infrared wavelengths of the spectrum has significantly expanded the applicability of fluorescence imaging. This paper focuses on the potential applications and limitations of non-invasive imaging techniques in the field of drug delivery, especially in anticancer therapy. Fluorescent imaging at both the cellular and systemic levels is discussed in detail. Additionally, we explore the possibility for simultaneous treatment and imaging using theranostics and combinations of different imaging techniques, e.g., fluorescence imaging with computed tomography.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x aplikace a dávkování $x farmakokinetika $7 D000970
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a fluorescence $7 D005453
650    _2
$a fluorescenční barviva $x chemie $7 D005456
650    _2
$a lidé $7 D006801
650    _2
$a nádory $x diagnóza $x farmakoterapie $7 D009369
650    _2
$a optické zobrazování $x metody $7 D061848
650    _2
$a teranostická nanomedicína $x metody $7 D000068936
650    _2
$a celotělové zobrazování $x metody $7 D051598
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Lucas, Henrike $u Martin-Luther-University Halle-Wittenberg, Dept. of Pharmacy, Pharmaceutical Technology and Biopharmacy, 06120 Halle, Germany; Martin-Luther-University Halle-Wittenberg, Dept. of Internal Medicine IV, Oncology/Hematology, 06120 Halle, Germany.
700    1_
$a Janoušková, Olga $u Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic.
700    1_
$a Chytil, Petr $u Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic.
700    1_
$a Mueller, Thomas $u Martin-Luther-University Halle-Wittenberg, Dept. of Internal Medicine IV, Oncology/Hematology, 06120 Halle, Germany.
700    1_
$a Mäder, Karsten $u Martin-Luther-University Halle-Wittenberg, Dept. of Pharmacy, Pharmaceutical Technology and Biopharmacy, 06120 Halle, Germany.
773    0_
$w MED00002621 $t Journal of controlled release official journal of the Controlled Release Society $x 1873-4995 $g Roč. 226, č. - (2016), s. 168-81
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26892751 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170118114053 $b ABA008
999    __
$a ok $b bmc $g 1179579 $s 961006
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 226 $c - $d 168-81 $e 20160216 $i 1873-4995 $m Journal of controlled release $n J Controlled Release $x MED00002621
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace